Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ephedrine
2. Ephedrine Erythro Isomer
3. Ephedrine Hydrochloride
4. Ephedrine Renaudin
5. Erythro Isomer Of Ephedrine
6. Hydrochloride, Ephedrine
7. Renaudin, Ephedrine
8. Sal Phedrine
9. Sal-phedrine
10. Salphedrine
11. Sulfate, Ephedrine
1. Ephedrine Sulphate
2. Isofedrol
3. Akovaz
4. 134-72-5
5. Corphedra
6. Ephedrine Sulfate [usp]
7. U6x61u5zeg
8. (-)-ephedrine Sulfate (2:1) (salt)
9. 134-72-5 (sulfate)
10. (-)-ephedrine Hemisulfate
11. Nci-c55652
12. Ephedrine Sulfate (usp)
13. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, (alphar)-, Sulfate (2:1) (salt)
14. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric Acid
15. L-ephedrine Sulfate
16. Unii-u6x61u5zeg
17. Expansyl
18. Ccris 1351
19. Ephedrini Sulfas
20. Pazo Ointment
21. Franol Plus
22. Franol-plus
23. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol Sulfate (2:1) (salt)
24. Pazo Suppositories
25. Corphedra (tn)
26. Emerphed (tn)
27. Einecs 205-154-4
28. Akovaz (tn)
29. Emerphed
30. Ephedrine L- Sulfate
31. 1-phenyl-2-methylamine-propanol-1-sulfate
32. Ec 205-154-4
33. Schembl41262
34. (1r,2s)-1-phenyl-2-methylaminopropanol-1 Sulfate
35. Ephedrine Sulfate [mi]
36. 1-alpha-(1-(methylamino)ethyl)benzyl Alcohol Sulfate
37. Chembl1523964
38. Dtxsid6020565
39. Ephedrine Sulfate [vandf]
40. Ephedrine Sulfate [mart.]
41. Ephedrine Sulfate [usp-rs]
42. Ephedrine Sulfate [who-dd]
43. Ephedrine Sulfate [who-ip]
44. (-)-erythro-1-hydroxy-2-(methylamino)-1-phenylpropane Sulfate
45. Bdbm50480314
46. Akos015901652
47. Ephedrine Sulfate [orange Book]
48. Ephedrini Sulfas [who-ip Latin]
49. Ephedrine Sulfate [usp Monograph]
50. Ncgc00093901-01
51. Ephedrine Sulfate (2:1) (salt), (-)-
52. Eu-0100501
53. D04018
54. E 3250
55. Q27290771
56. Ephedrine Sulphate 1.0 Mg/ml In Methanol (as Free Base)
57. Bis((r-(r*,s*))-beta-hydroxy-alpha-methylphenethyl)methylammonium Sulphate
58. Bis((r-(r*,s*))-beta-hydroxy-alpha-methylphenethyl)methylammonium) Sulphate
59. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, (alphar)-, Sulfate (2:1)
60. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (r-(r*,s*))-, Sulfate (2:1) (salt)
61. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (theta-(theta,s))-, Sulfate (2:1) (salt)
62. (r-(r*,s*))-.alpha.-(1-(methylamino)ethyl)benzenemethanol Sulfate (2:1) (salt) [who-ip]
63. Benzenemethanol, .alpha.-(1-(methylamino)ethyl)-, (r-(r*,s*))-, Sulfate (2:1) (salt)
Molecular Weight | 428.5 g/mol |
---|---|
Molecular Formula | C20H32N2O6S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 428.19810792 g/mol |
Monoisotopic Mass | 428.19810792 g/mol |
Topological Polar Surface Area | 148 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 202 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Ephedrine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ephedrine Sulfate manufacturer or Ephedrine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ephedrine Sulfate manufacturer or Ephedrine Sulfate supplier.
PharmaCompass also assists you with knowing the Ephedrine Sulfate API Price utilized in the formulation of products. Ephedrine Sulfate API Price is not always fixed or binding as the Ephedrine Sulfate Price is obtained through a variety of data sources. The Ephedrine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AKOVAZ manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOVAZ, including repackagers and relabelers. The FDA regulates AKOVAZ manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOVAZ API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AKOVAZ manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AKOVAZ supplier is an individual or a company that provides AKOVAZ active pharmaceutical ingredient (API) or AKOVAZ finished formulations upon request. The AKOVAZ suppliers may include AKOVAZ API manufacturers, exporters, distributors and traders.
click here to find a list of AKOVAZ suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AKOVAZ DMF (Drug Master File) is a document detailing the whole manufacturing process of AKOVAZ active pharmaceutical ingredient (API) in detail. Different forms of AKOVAZ DMFs exist exist since differing nations have different regulations, such as AKOVAZ USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AKOVAZ DMF submitted to regulatory agencies in the US is known as a USDMF. AKOVAZ USDMF includes data on AKOVAZ's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AKOVAZ USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AKOVAZ suppliers with USDMF on PharmaCompass.
A AKOVAZ written confirmation (AKOVAZ WC) is an official document issued by a regulatory agency to a AKOVAZ manufacturer, verifying that the manufacturing facility of a AKOVAZ active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AKOVAZ APIs or AKOVAZ finished pharmaceutical products to another nation, regulatory agencies frequently require a AKOVAZ WC (written confirmation) as part of the regulatory process.
click here to find a list of AKOVAZ suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AKOVAZ as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AKOVAZ API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AKOVAZ as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AKOVAZ and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AKOVAZ NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AKOVAZ suppliers with NDC on PharmaCompass.
AKOVAZ Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AKOVAZ GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AKOVAZ GMP manufacturer or AKOVAZ GMP API supplier for your needs.
A AKOVAZ CoA (Certificate of Analysis) is a formal document that attests to AKOVAZ's compliance with AKOVAZ specifications and serves as a tool for batch-level quality control.
AKOVAZ CoA mostly includes findings from lab analyses of a specific batch. For each AKOVAZ CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AKOVAZ may be tested according to a variety of international standards, such as European Pharmacopoeia (AKOVAZ EP), AKOVAZ JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AKOVAZ USP).